PRICE T ROWE ASSOCIATES INC /MD/
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 80255
BALTIMORE, MD
Position in ARWR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$69,557,372
+$4,115,376 QoQ
Shares Held
853,360
-18.2% QoQ
Ownership
0.604%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#31
of 497 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,963,376 across 304 Biotechnology names. ARWR ranks #61 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in ARWR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $69,557,372 | 853,360 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $65,441,996 | 1,043,732 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $55,689,126 | 838,818 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,802,350 | 110,245 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,589,606 | 100,608 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,187,227 | 93,189 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,426,130 | 75,858 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,481,766 | 76,498 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,920,609 | 73,898 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,034,489 | 71,136 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,853,380 | 60,568 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $1,359,299 | 50,588 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,951,529 | 54,726 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,321,308 | 52,020 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,058,825 | 50,760 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,681,650 | 50,882 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,626,209 | 46,186 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,241,598 | 48,741 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,960,759 | 44,657 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,975,850 | 47,667 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,937,179 | 47,539 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,381,611 | 50,997 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $4,255,982 | 55,467 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,069,144 | 71,276 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $3,007,146 | 69,626 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,733,536 | 60,255 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||